Accurately diagnosing and staging patients with upper tract urothelial carcinoma (UTUC) has proven challenging for clinicians. Experts at Memorial Sloan Kettering recently applied genomic ...

Credit: Thinkstock Investigators explored the potential of a noninvasive ctDNA assay as a predictive biomarker for advanced or metastatic urothelial cancer. Increases in circulating tumor DNA ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

Cxbladder Monitor accurately rules out recurrent urothelial carcinoma ... patients likely to have high-grade or late-stage bladder cancer. When selecting exclusively for high-grade or late ...

The National Comprehensive Cancer Network recommends that all patients with stage IVA and stage IVB urothelial carcinoma have molecular analysis that integrates at least FGFR3 testing to help ...

Both tests showed lower accuracy in the evaluation of patients with a history of urothelial cancer than in patients with hematuria, CT urography more so than cystoscopy (77.8% vs 84.8%).

In this study we aimed to evaluate the protein expression of class I HDACs in urothelial carcinoma of the bladder. Methods: A tissue microarray containing 348 tissuesamples from 174 patients with ...

Urothelial cancer, which accounts for 90% of all bladder cancers, is a debilitating and frequently aggressive cancer. When the disease is diagnosed at a late stage, survival rates are often extremely ...

Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, ...